![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Open public recruiting |
Unique ID issued by UMIN | UMIN000040320 |
Receipt No. | R000045802 |
Scientific Title | Exploratory clinical research of Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections |
Date of disclosure of the study information | 2020/05/07 |
Last modified on | 2021/01/06 |
Basic information | ||
Public title | Appropriate Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections in Japanese over 50 years-old adults | |
Acronym | Appropriate Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections | |
Scientific Title | Exploratory clinical research of Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections | |
Scientific Title:Acronym | Appropriate Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections | |
Region |
|
Condition | |||
Condition | None | ||
Classification by specialty |
|
||
Classification by malignancy | Others | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | This study aims to assess appropriate needle length for intra-muscular (IM) injection for subjects targeted on over 50 years-old Japanese adults. |
Basic objectives2 | Others |
Basic objectives -Others | Appropriate Needle Length Determined Using Ultrasonic Echograms for Intramuscular Injections |
Trial characteristics_1 | Others |
Trial characteristics_2 | Pragmatic |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | Analyze the thickness of the epidermis, subcutaneous tissue, and muscle tissues based on the different intensities of echograms. The correlation between the subcutaneous lengths and the body size is investigated. |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Non-randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Uncontrolled |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 1 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | Measurement and Ulterasonic echogram of center of deltoid muscle area of upper arm | |
Interventions/Control_2 | ||
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 50 subjects aged 50-64 years, 50 subjects aged 65-74 years, and 60 subjects aged >75 years (20 for each group: Outpatients, Elderly needed nursing care, and Elderly on bedridden)
(1) Adults and elderly who assigned the informed consent. (2) Elderly in a nursing home who assigned the informed consent by themselves or legal representatives. (3) Subjects with non-serious transient illness (upper respiratory infection, etc.) and those with chronic ailments are included when principal investigator (PI)/ sub investigator (SI) consider possible to participate the study. (4) Japanese adults (born in Japan, and speak Japanese.) <Reasons for settings> (1) Based on the ethical reasons (2) Based on the ethical reasons (3) Excluding the influence of echogram on health condition and safety assurance. (4) Investigation for Japanese adults. |
|||
Key exclusion criteria | (1) Adults and elderly with some problems at the deltoid area
(2) Subjects who have some problems on measuring the circumference or Echogram judged by PI or SI. (3) Adults and elderly with acute or chronic serious illness. (4) Adults and elderly with some disorder at upper limb. (5) Adults and elderly suffering from neurological or muscular illness or with the history of these illness. (6) Subjects who are judged as not appropriate by PI or SI. (7) Adults and elderly without informed consent by themselves or a legal representative. Reasons for settings (1)-(6) These items have potential influence on measuring the circumference and length of subcutaneous tissues. (6) for safety assurance (7) for securing the neutrality and ethical matters. |
|||
Target sample size | 160 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Kitasato University | ||||||
Division name | Omura Satoshi Memorial Institute | ||||||
Zip code | 108-8641 | ||||||
Address | 5-9-1 Shirokane, Minato-ku, Tokyo | ||||||
TEL | 03-5791-6269 | ||||||
tetsuo-n@lisci.kitasato-u.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Kitasato University | ||||||
Division name | Omura Satoshi Memorial Institute | ||||||
Zip code | 108-8641 | ||||||
Address | 5-9-1 Shirokane Minato-ku, Tokyo | ||||||
TEL | 03-5791-6269 | ||||||
Homepage URL | |||||||
tetsuo-n@lisci.kitasato-u.ac.jp |
Sponsor | |
Institute | Kitasato University
Omura Satoshi Memorial Institute |
Institute | |
Department |
Funding Source | |
Organization | GlaxoSmithkline Biologicals |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization | Belgium |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Ethics Committee, Kitasato Institute Hospital |
Address | 5-9-1 ShiroKane Minato-ku, Tokyo 108-8641 |
Tel | 03-5791-6106 |
kenkyu@insti.kitasato-u.ac.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Open public recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045802 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |